Elevated levels of VCAM-1 and ICAM-1 have been reported in the CSF of CIDP and GBS patients18 explaining the predictive value of this marker in the differential diagnosis of ALS. This evidence concerns the gene ICAM1 and Guillain-Barre syndrome.